Highlander Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $77.8K | Hold |
150
| – | – | 0.03% | 330 |
|
|
2023
Q4 | $70.7K | Hold |
150
| – | – | 0.03% | 337 |
|
|
2023
Q3 | $65K | Hold |
150
| – | – | 0.03% | 339 |
|
|
2023
Q2 | $67K | Hold |
150
| – | – | 0.03% | 286 |
|
|
2023
Q1 | $69K | Hold |
150
| – | – | 0.03% | 276 |
|
|
2022
Q4 | $77K | Hold |
150
| – | – | 0.04% | 246 |
|
|
2022
Q3 | $68K | Hold |
150
| – | – | 0.04% | 248 |
|
|
2022
Q2 | $72K | Hold |
150
| – | – | 0.04% | 247 |
|
|
2022
Q1 | $74K | Hold |
150
| – | – | 0.03% | 249 |
|
|
2021
Q4 | $70K | Hold |
150
| – | – | 0.03% | 247 |
|
|
2021
Q3 | $56K | Hold |
150
| – | – | 0.03% | 266 |
|
|
2021
Q2 | $57K | Hold |
150
| – | – | 0.03% | 276 |
|
|
2021
Q1 | $54K | Hold |
150
| – | – | 0.03% | 279 |
|
|
2020
Q4 | $48K | Hold |
150
| – | – | 0.03% | 298 |
|
|
2020
Q3 | $40K | Hold |
150
| – | – | 0.02% | 312 |
|
|
2020
Q2 | $39K | Hold |
150
| – | – | 0.02% | 313 |
|
|
2020
Q1 | $34K | Hold |
150
| – | – | 0.02% | 329 |
|
|
2019
Q4 | $45K | Hold |
150
| – | – | 0.03% | 317 |
|
|
2019
Q3 | $36K | Hold |
150
| – | – | 0.02% | 339 |
|
|
2019
Q2 | $42K | Hold |
150
| – | – | 0.03% | 338 |
|
|
2019
Q1 | $43K | Hold |
150
| – | – | 0.03% | 340 |
|
|
2018
Q4 | $39K | Hold |
150
| – | – | 0.03% | 341 |
|
|
2018
Q3 | $41K | Hold |
150
| – | – | 0.02% | 377 |
|
|
2018
Q2 | $36K | Hold |
150
| – | – | 0.02% | 398 |
|
|
2018
Q1 | $33K | Hold |
150
| – | – | 0.02% | 410 |
|
|
2017
Q4 | $34K | Hold |
150
| – | – | 0.02% | 405 |
|
|
2017
Q3 | $28K | Hold |
150
| – | – | 0.02% | 440 |
|
|
2017
Q2 | $28K | Hold |
150
| – | – | 0.02% | 444 |
|
|
2017
Q1 | $25K | Hold |
150
| – | – | 0.02% | 467 |
|
|
2016
Q4 | $22K | Hold |
150
| – | – | 0.02% | 494 |
|
|
2016
Q3 | $19K | Hold |
150
| – | – | 0.02% | 530 |
|
|
2016
Q2 | $20K | Hold |
150
| – | – | 0.02% | 524 |
|
|
2016
Q1 | $21K | Sell |
150
-100
| -40% | -$13.4K | 0.02% | 511 |
|
|
2015
Q4 | $35K | Hold |
250
| – | – | 0.03% | 422 |
|
|
2015
Q3 | $35K | Hold |
250
| – | – | 0.03% | 434 |
|
|
2015
Q2 | $41K | Hold |
250
| – | – | 0.04% | 408 |
|
|
2015
Q1 | $39K | Hold |
250
| – | – | 0.03% | 429 |
|
|
2014
Q4 | $31K | Sell |
250
-592
| -70% | -$73.2K | 0.03% | 468 |
|
|
2014
Q3 | $101K | Hold |
842
| – | – | 0.1% | 231 |
|
|
2014
Q2 | $90.6K | Hold |
842
| – | – | 0.08% | 250 |
|
|
2014
Q1 | $83.8K | Hold |
842
| – | – | 0.08% | 253 |
|
|
2013
Q4 | $77.8K | Hold |
842
| – | – | 0.07% | 269 |
|
|
2013
Q3 | $70.4K | Hold |
842
| – | – | 0.07% | 279 |
|
|
2013
Q2 | $68.9K | Buy |
+842
| New | +$63K | 0.07% | 272 |
|
Other funds holding ELV
Highlander Capital Management's ELV Position: Q1 2024 in Review
Highlander Capital Management held its Elevance Health (ELV) position steady in Q1 2024 at 150 shares worth $77.8K. The position accounts for 0.03% of the portfolio, ranked #330.
Highlander Capital Management first reported a position in ELV in Q2 2013 and has held it in 44 quarters since. The position peaked at $101K in Q3 2014. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Highlander Capital Management held 150 shares of Elevance Health worth $77.8K as of Q1 2024.
- Highlander Capital Management left its Elevance Health share count unchanged in Q1 2024.
- Elevance Health made up 0.03% of Highlander Capital Management's portfolio in Q1 2024, its #330 holding.
- Highlander Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 44 quarters since.
- Highlander Capital Management's Elevance Health position peaked at $101K in Q3 2014.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.